Shenzhen, China

Gailing Li

This inventor holds 1 USPTO granted patent and 2 published patent applications and 3 EPO patents. Top assignee: Genemind Biosciences Company Limited. Active years: 2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Gailing Li. Retrieved from https://idiyas.com/inventor/gailing-li

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

 

Average Co-Inventor Count = 7.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Gailing Li: Innovator in Nucleic Acid Fragment Ligation

Introduction

Gailing Li is a prominent inventor based in Shenzhen, China. He has made significant contributions to the field of molecular biology, particularly in the area of nucleic acid manipulation. His innovative methods have the potential to enhance the efficiency of genetic research and applications.

Latest Patents

Gailing Li holds a patent for a "Method for ligating nucleic acid fragments, method for constructing sequencing library, and use." This patent discloses a method for ligating nucleic acid fragments, which involves a mixed enzyme reaction system comprising a DNA ligase and an RNA ligase. The method achieves a ligation efficiency of 85% or more, significantly improving the yield of effective sequencing libraries.

Career Highlights

Gailing Li is associated with Genemind Biosciences Company Limited, where he applies his expertise in nucleic acid technologies. His work focuses on developing innovative solutions that advance genetic research and biotechnology.

Collaborations

Gailing Li collaborates with notable colleagues, including Guangli Gan and Qunting Lin. Their combined efforts contribute to the advancement of research in molecular biology and related fields.

Conclusion

Gailing Li's contributions to the field of nucleic acid ligation represent a significant advancement in biotechnology. His innovative methods and collaborative efforts continue to influence genetic research and applications.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…